CA2173272C - Stimulation de cellules souches et d'autres cellules - Google Patents

Stimulation de cellules souches et d'autres cellules Download PDF

Info

Publication number
CA2173272C
CA2173272C CA 2173272 CA2173272A CA2173272C CA 2173272 C CA2173272 C CA 2173272C CA 2173272 CA2173272 CA 2173272 CA 2173272 A CA2173272 A CA 2173272A CA 2173272 C CA2173272 C CA 2173272C
Authority
CA
Canada
Prior art keywords
hyaluronic acid
production
pharmaceutically acceptable
acceptable salts
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2173272
Other languages
English (en)
Other versions
CA2173272A1 (fr
Inventor
Linda May Pilarski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA 2173272 priority Critical patent/CA2173272C/fr
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to AU20888/97A priority patent/AU2088897A/en
Priority to DE69723702T priority patent/DE69723702T2/de
Priority to DK97906061T priority patent/DK0914133T3/da
Priority to PT97906061T priority patent/PT914133E/pt
Priority to PCT/CA1997/000172 priority patent/WO1997033592A1/fr
Priority to AT97906061T priority patent/ATE245424T1/de
Priority to US09/142,557 priority patent/US6875753B1/en
Priority to ES97906061T priority patent/ES2202581T3/es
Priority to EP97906061A priority patent/EP0914133B1/fr
Priority to ARP970101001A priority patent/AR006214A1/es
Publication of CA2173272A1 publication Critical patent/CA2173272A1/fr
Application granted granted Critical
Publication of CA2173272C publication Critical patent/CA2173272C/fr
Priority to US10/948,957 priority patent/US7446100B2/en
Priority to US10/950,155 priority patent/US20050113335A1/en
Priority to US10/949,033 priority patent/US20050101564A1/en
Priority to US12/237,283 priority patent/US20090041733A1/en
Priority to US12/237,267 priority patent/US20090029941A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA 2173272 1996-03-14 1996-04-02 Stimulation de cellules souches et d'autres cellules Expired - Fee Related CA2173272C (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CA 2173272 CA2173272C (fr) 1996-04-02 1996-04-02 Stimulation de cellules souches et d'autres cellules
EP97906061A EP0914133B1 (fr) 1996-03-14 1997-03-12 Utilisation de l'hyaluronane (ha) pour la mobilisation cellulaire
DK97906061T DK0914133T3 (da) 1996-03-14 1997-03-12 Anvendelse af hyaluronan (HA) til cellemobilisering
PT97906061T PT914133E (pt) 1996-03-14 1997-03-12 Utilizacao de hialuronano (ha) para mobilizacao de celulas
PCT/CA1997/000172 WO1997033592A1 (fr) 1996-03-14 1997-03-12 Procedes de mobilisation cellulaire a l'aide d'un traitement in vivo utilisant l'hyaluronan (ha)
AT97906061T ATE245424T1 (de) 1996-03-14 1997-03-12 Verwendung von hyaluronsäure zur zellmobilisierung
US09/142,557 US6875753B1 (en) 1996-03-14 1997-03-12 Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
ES97906061T ES2202581T3 (es) 1996-03-14 1997-03-12 Uso de hialuronan (ha) para la movilizacion celular.
AU20888/97A AU2088897A (en) 1996-03-14 1997-03-12 Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
DE69723702T DE69723702T2 (de) 1996-03-14 1997-03-12 Verwendung von hyaluronsäure zur zellmobilisierung
ARP970101001A AR006214A1 (es) 1996-03-14 1997-03-13 Un metodo para movilizar celulas mediante el tratamiento con hialuronan (ha)
US10/948,957 US7446100B2 (en) 1996-03-14 2004-09-24 Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US10/950,155 US20050113335A1 (en) 1996-04-02 2004-09-24 Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US10/949,033 US20050101564A1 (en) 1996-04-02 2004-09-24 Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US12/237,283 US20090041733A1 (en) 1996-03-14 2008-09-24 Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
US12/237,267 US20090029941A1 (en) 1996-03-14 2008-09-24 Methods for cell mobilization using in vivo treatment with hyaluronan (ha)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2173272 CA2173272C (fr) 1996-04-02 1996-04-02 Stimulation de cellules souches et d'autres cellules

Publications (2)

Publication Number Publication Date
CA2173272A1 CA2173272A1 (fr) 1997-10-03
CA2173272C true CA2173272C (fr) 2001-08-28

Family

ID=4157882

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2173272 Expired - Fee Related CA2173272C (fr) 1996-03-14 1996-04-02 Stimulation de cellules souches et d'autres cellules

Country Status (1)

Country Link
CA (1) CA2173272C (fr)

Also Published As

Publication number Publication date
CA2173272A1 (fr) 1997-10-03

Similar Documents

Publication Publication Date Title
JP2613605B2 (ja) 抗菌物質として有効なヒアルロン酸の重金属塩
US20090041733A1 (en) Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
JPH08500623A (ja) 新規グルカン調製物
CA2417867C (fr) Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes
WO1987005517A1 (fr) Sels de metaux lourds de l'acide hyaluronique utiles en tant qu'agents antimicrobiens
JPH09512797A (ja) 癌の治療および転移の予防
US20220031701A1 (en) Compositions and methods for treating diseases associated with uncontrolled inflammatory responses
EP0952855A1 (fr) Utilisation de hyaluronan dans la therapie genique
JPH08500838A (ja) 細胞損傷または枯渇の治療法
CN104487066B (zh) 放射线损害的预防和/或治疗剂
Khwaja et al. Recombinant human granulocyte‐macrophage colony‐stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double‐blind, placebo‐controlled trial
EP0557118A1 (fr) Utilisation de l'acide hyaluronique pour remettre l'ischémie due à la reperfusion
EP0695187B1 (fr) Inhibition, controle et regression de l'angiogenese a l'aide d'acide hyaluronique ou d'acide hyaluronique et des ains
US20030175332A1 (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
EP0914133B1 (fr) Utilisation de l'hyaluronane (ha) pour la mobilisation cellulaire
CA2173272C (fr) Stimulation de cellules souches et d'autres cellules
EP0651654B1 (fr) Utilisation de dimère de lysozyme pour la fabrication d'un médicament pour moduler les mécanismes naturels de défense.
Clarke et al. Lisofylline inhibits transforming growth factor β release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice
Prisnyi et al. The comparative analysis of the influence of fluorochinolones on the blood leucogram of chickens
Moiseeva et al. Leukocytes differential under effect of ciprofloxacin in experimental colibacillosis in chickens
US20050101564A1 (en) Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
Prisnyi et al. Effects of ciprofloxacin on chicken blood parameters after an experimental infection
Eaves-Pyles et al. Granulocyte colony-stimulating factor enhances killing of translocated bacteria but does not affect barrier function in a burn mouse model
TW201121965A (en) Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN106166291B (zh) 脾多肽提高klrk1或lck治疗免疫抑制的医药用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed